Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India
· Delayed Price · Currency is INR 131.00
-0.10 (-0.08%)
At close: Jul 11, 2025
NSE:ARISTO Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2019 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2019 - 2020 |
Operating Revenue | 3,181 | 2,451 | 2,179 | 1,658 | 1,672 | Upgrade
|
Other Revenue | - | 0 | - | - | - | Upgrade
|
| 3,181 | 2,451 | 2,179 | 1,658 | 1,672 | Upgrade
| |
Revenue Growth (YoY) | 29.75% | 12.53% | 31.43% | -0.87% | -16.90% | Upgrade
|
Cost of Revenue | 2,955 | 2,260 | 1,960 | 1,472 | 1,502 | Upgrade
|
Gross Profit | 225.59 | 191.1 | 218.55 | 185.63 | 170.66 | Upgrade
|
Selling, General & Admin | 40.99 | 37.28 | 58.42 | 53.94 | 36.3 | Upgrade
|
Other Operating Expenses | 91.86 | 68.18 | 72.19 | 79.36 | 90.91 | Upgrade
|
Operating Expenses | 158.87 | 121.16 | 145.97 | 144.29 | 134.71 | Upgrade
|
Operating Income | 66.71 | 69.94 | 72.58 | 41.34 | 35.95 | Upgrade
|
Interest Expense | -16.58 | -16.68 | -22.07 | -18.82 | -22.09 | Upgrade
|
Interest & Investment Income | - | 0.46 | 0.56 | 0.24 | 0.12 | Upgrade
|
Currency Exchange Gain (Loss) | - | 0.8 | -2.42 | -0.1 | 2.06 | Upgrade
|
Other Non Operating Income (Expenses) | 4.54 | -0.45 | -1.26 | -2.42 | -1.05 | Upgrade
|
EBT Excluding Unusual Items | 54.67 | 54.08 | 47.39 | 20.25 | 14.98 | Upgrade
|
Gain (Loss) on Sale of Assets | - | -0 | - | 0.16 | - | Upgrade
|
Asset Writedown | - | - | - | -0.6 | - | Upgrade
|
Pretax Income | 54.67 | 54.08 | 47.39 | 19.8 | 14.98 | Upgrade
|
Income Tax Expense | 14.04 | 15.12 | 11.77 | 5.47 | 4.22 | Upgrade
|
Net Income | 40.63 | 38.96 | 35.62 | 14.34 | 10.76 | Upgrade
|
Net Income to Common | 40.63 | 38.96 | 35.62 | 14.34 | 10.76 | Upgrade
|
Net Income Growth | 4.30% | 9.36% | 148.44% | 33.29% | 6.78% | Upgrade
|
Shares Outstanding (Basic) | 7 | 7 | 5 | 5 | 5 | Upgrade
|
Shares Outstanding (Diluted) | 7 | 7 | 5 | 5 | 5 | Upgrade
|
Shares Change (YoY) | -0.03% | 28.43% | 6.13% | - | - | Upgrade
|
EPS (Basic) | 5.97 | 5.72 | 6.72 | 2.87 | 2.15 | Upgrade
|
EPS (Diluted) | 5.97 | 5.72 | 6.72 | 2.87 | 2.15 | Upgrade
|
EPS Growth | 4.37% | -14.88% | 134.14% | 33.27% | 6.78% | Upgrade
|
Free Cash Flow | 49.1 | 10.45 | -68.44 | 35.29 | 2.95 | Upgrade
|
Free Cash Flow Per Share | 7.21 | 1.54 | -12.91 | 7.07 | 0.59 | Upgrade
|
Dividend Per Share | 0.500 | 0.400 | 0.250 | - | - | Upgrade
|
Dividend Growth | 25.00% | 60.00% | - | - | - | Upgrade
|
Gross Margin | 7.09% | 7.80% | 10.03% | 11.20% | 10.21% | Upgrade
|
Operating Margin | 2.10% | 2.85% | 3.33% | 2.49% | 2.15% | Upgrade
|
Profit Margin | 1.28% | 1.59% | 1.64% | 0.86% | 0.64% | Upgrade
|
Free Cash Flow Margin | 1.54% | 0.43% | -3.14% | 2.13% | 0.18% | Upgrade
|
EBITDA | 92.74 | 85.65 | 87.95 | 52.33 | 43.44 | Upgrade
|
EBITDA Margin | 2.92% | 3.49% | 4.04% | 3.16% | 2.60% | Upgrade
|
D&A For EBITDA | 26.02 | 15.71 | 15.36 | 10.99 | 7.49 | Upgrade
|
EBIT | 66.71 | 69.94 | 72.58 | 41.34 | 35.95 | Upgrade
|
EBIT Margin | 2.10% | 2.85% | 3.33% | 2.49% | 2.15% | Upgrade
|
Effective Tax Rate | 25.68% | 27.96% | 24.83% | 27.60% | 28.20% | Upgrade
|
Revenue as Reported | 3,185 | 2,453 | 2,182 | 1,660 | 1,672 | Upgrade
|
Advertising Expenses | - | 0.3 | 0.25 | 0.04 | 0.04 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.